Augmate

Augmate

ICO Ended
16,175 Views
As an original Google Glass @ Work partner, Augmate was originally created to serve the needs of workers using wearable glasses. There were many application developers for wearable glasses, but there were no device management platforms for IT to centrally control all of the new devices coming onto their systems. Our CEO, Pete Wassell led the creation of an industrial-strength platform that would make controlling these devices simple and more complete for securing and provisioning them.

The basic premise of Augmate is to allow control of multiple, disparate devices easily and efficiently without sacrificing security in the data. It acts as a software layer that in the past, resided on the devices just over the operating system. Signed by the keys of the device, the code allowed for virtually full control of that device from a web based portal.

Augmate is upgrading its infrastructure to leverage distributed ledger technology in order to refine data security and put users back in control of their own data. At its core, Augmate Connect will be a blockchain-agnostic platform, and may eventually integrate other private and public blockchain protocols bringing interoperability to device management.
6.3
TOTAL SCORE
7.3
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 01 Jan 2018 - 30 June 2018
Country: USA
Token info
Ticker: MATE
Platform: Ethereum
Token Type: ERC20
Available for sale: 15,000,000,000 MATE (30%)
Financial
ICO Price: 1 MATE = 0.015 USD
Accepting: ETH
2017
IoT Expansion Task Force. IOTA Connection. Whitepaper. Pilot-in-a-Box. IOTA POC. Conferences & Marketing.
2018
Augmate Connect Platform Rollout. EOS and Ethereum POC. Asia Expansion. Expanded Alliance Partnerships.<br /> <br /> Pilots Moved into Production. API Strategy Begun.
2019
Enterprise Strategy in Full Swing. Consumer Strategy Completed. Consumer Roll Out.
2020 +
Market Integration with API Strategy Realized. Consumer Strategy in Full Swing.
Screenshots taken on 16 Feb 2018
Pete Wassell
Founder, CEO
No participating data
Dana Farbo
COO
No participating data
Eddie Quiroz
CIO
No participating data
Bob Visnov
CTO
No participating data
Thomas Miller
CCO & CMO
No participating data
Peter Orban
Chief Commercial Officer
No participating data
Stephen Pelletier
No participating data
William Hickey
No participating data
Harv Lotko
No participating data

Advisors (7)

Margaux Avedisian
Advisor
No participating data
Joseph Daniels
Advisor
No participating data
Cristina Dolan
Advisor
No participating data
Benjamin Kraus
Advisor
No participating data
Gregory Rocco
Advisor
No participating data
Bryan Feinberg
Advisor
No participating data
Matt Garza
Advisor
No participating data
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Vidy
Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.
Upcoming
Orion Protocol
ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.
Upcoming
Apillon
Apillon is a Web3 development platform empowering developers to build in the Polkadot ecosystem. Through standard API connections, it provides the complete technology stack of connected services for creating NFT, GameFi, DeFi, and other Web3 products easily, reliably, and fast.
Upcoming
Universal Reward Protocol
By accepting to share their shopping data with the network, a shopper earns reward tokens, while the data is used by retailers to build redemption offers that best suit each customer’s needs. Shoppers can redeem their tokens through these exclusive and personalized offers.
Upcoming
Bithemoth
Here at Bithemoth, we strive for excellence and the development of the blockchain world. Through a vigorous and highly intensive process, we selected strong and innovative leaders to become apart of the Bithemoth family and project. Our team stretches across the globe and with a diversity of strengths we will be able to make a huge impact in the blockchain world. Our ecosystem will include: 1. A Decentralized Digital Asset Exchange
 2. Enhanced and Revolutionary Security and Features
 3. A complete Marketplace and Trading Platform
 4. Fully supported ICO incubator
 5. Dedicated Support Systems and Infrastructure
 6. The Development of Brick and Mortar Locations

Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.